1. Homepage
  2. Equities
  3. Italy
  4. Borsa Italiana
  5. EL.En. S.p.A.
  6. News
  7. Summary
    ELN   IT0005453250

EL.EN. S.P.A.

(ELN)
  Report
Real-time Estimate Cboe Europe  -  05/23 08:06:30 am EDT
12.42 EUR   -0.96%
05/23EL.EN. S.P.A. : Ex-dividend day for final dividend
FA
05/16TRANSCRIPT : EL.En. S.p.A., Q1 2022 Earnings Call, May 16, 2022
CI
04/29EL EN S P A : Ordinary and Special Shareholder's meeting of El.En. S.p.A.
PU
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

EL En S p A : The Bod of El.En. approves the financial report as of March 31st 2021

05/14/2021 | 09:57am EDT

2.2

3.1 REGEM

Press release

The Bod of El.En. approves the financial report

as of March 31st 2021

Record results for the Group in the first quarter

Improved guidance

  • Consolidated Revenues: 116,4 million of euro up 60% on the 73 million of euro of 1Q, 2020
  • EBITDA: 15,6 million of euro vs. 7,1 million of euro in 2020 ( up 120%)
  • EBIT: 12,9 million of euro vs. 4,5 million of euro in (up 187,5%)
  • Net financial position: cash positive for 75,8 million of euro up on the 69,2 million as of December 21st, 2020

Florence, May 14, 2021 - The Board of Directors of El.En. S.p.A., leader on the laser market and listed on the STAR segment of the Italian Stock Exchange, approved today the financial report as of March 31, 2021.

In the first three months of 2021 the El.En. Group recorded consolidated revenues for 116,4 million of euro , with an approximately 60% increase compared to the 73 million of euro of March 31, 2020 and an EBIT of 12,9 million of euro, up approximately 187,5% on the 4,5 million of euro as of March 31, 2020, and with an EBIT margin of 11.1%.

Gabriele Clementi, President of El.En. said: "We can't hide our great satisfaction in sharing with the market the excellent result of the first quarter of 2021 which confirms, albeit still in an uncertainty climate, the signs of recovery already recorded in the second half of 2020. The reference markets of the Group are offering important opportunities. In several areas we have already recovered what was lost due to the pandemic and we expect to perform even better over the next few months thanks also to a significant order backlog that allows us to look to the future with confidence, confirming, at the moment, the expectation of a significant increase in turnover and profitability"

The fortieth anniversary of the foundation of El.En. was just celebrated, an anniversary that falls in a particularly flourishing period of the Group's activities, testifying to the great initial intuition of the founders and the great quality and intensity of the work performed by themselves and by all the collaborators of the Group in recent years.

Just a few days before this anniversary, Prof. Leonardo Masotti left us. He was one of the two founders of El.En., its scientific soul, inspirer of the most significant innovative products and applications, university professor who generously disseminated his knowledge among his students and within all the functions and structures of El.En.. We remember him with affection and gratitude.

In the first quarter of 2021, in continuity with the end of 2020, the growth progression of the Group continued after the parenthesis due to the effects of Covid, with a level of turnover and profitability

1

back in line with the forecasts outlined before the pandemic. While 2020 was characterized by the Group's resilience to the pandemic, during which it was able to stay profitable and maintain a positive trend and revenue growth despite the profoundly adverse conditions, the first quarter of 2021 showed very brilliant results. The activities and investments made in the recent years in order to facilitate the planned growth in the various sectors in which the Group operates, begin in these months to materialize in the expected results.

The effects of the pandemic still continue to affect daily life and economic activities, with inconveniences and problems that spread negatively on numerous markets. The Group's operational activities in Europe are still limited by access protocols for companies, by the use of smart working as a security measure to reduce presence in offices and by the impossibility, or difficulty, of international traveling. Thanks to the positive reaction to the effects of the pandemic in some market niches, to the excellent and proactive work of the Group's operating structures and to the ability to continuously feed, even during the pandemic, the distribution networks with innovative products of great interest to customers, the Group is in recent months collecting the excellent results that we present together with a backlog at historic highs.

All the companies of the Group adopted since the beginning of the spread of the pandemic safety protocols aimed at preserving the health of employees and collaborators, securing offices and laboratories with precautionary measures and in compliance with the directives aimed at guaranteeing the tranquility of workers. Remote work has been widely adopted, although the lack of direct interaction is a major limitation to the effectiveness and creativity of many vital operational functions, above all research and development and marketing. The safety procedures adopted are still in force according to the protocols agreed with the employees and periodically updated. During the first quarter of 2021, the daily life and activities of the Group took place under almost normal conditions but above all without forced interruptions.

The commercial structures were able to benefit from the range of innovations introduced in 2020, pending the new additions planned for 2021 to further contribute to the success of the sales activity.

In the industrial sector, the improvement of the performance of laser cutting systems continues, with 30KW sources now firmly in our sales catalogs.

In the medical sector, Nd: YAG and Alexandrite systems launched in the second half of 2020 have been the driving force in hair removal, while for body contouring the technology of high intensity magnetic fields joins the functions added to the flagship Onda system, based on the localized and selective microwave emission. TFL systems (fiber optic laser with Tullium source) are entering a phase of introduction on the market and there will be several more products to see the light in 2021.

We are experiencing a widespread problem at a global level, in obtaining timely supplies on various materials. The delivery delays of certain electronic, opto-electronic, plastic and metal components became longer in recent months, creating some difficulties for the production processes. Although this led to lower efficiency of the production processes, increase in the costs of components and need to increase stocks of raw materials, the Group is positively continuing all its activities.

As part of our activity for the conservation of artistic heritage, in recent months we have started a collaboration of great prestige, engaging two sophisticated systems for cleaning the surfaces of Notre Dame in Paris, deeply damaged by the carbon black of the 2019 fire. At the moment the two lasers are successfully operating on the chapels dedicated to Our Lady of Guadalupe and San Ferdinando.

One year after the spread of the pandemic from the epicenter of Wuhan to the whole world, the Group is resolutely emerging from the subsequent impasse. Although still in anomalous and uncertain conditions of the markets on which the Group operates, very positive results were achieved.

2

In the 1Q of 2021, revenues showed a significant increase of about 60%, more marked in the industrial sector. The Medical sector recorded a growth of approximately 26% compared to the same period of 2020 with a turnover of 67.2 million euros compared to 53.5 million euros in 1Q 2020. The Industrial sector recorded revenues up by about 153% at 49.1 million euros vs. 19.4 million euros in the first quarter of 2020. It should be emphasized that beyond the comparison with the first quarter of 2020, that was already heavily penalized by the spread of the pandemic in China and Italy, the results of this 2021 are very positive in absolute value.

Within the medical and aesthetic systems sector, which accounts for 57% of revenues, there was a strong recovery in the Aesthetics and Therapy segments which grew by 52,0% and 44,2% respectively. The leap in sales of aesthetics assumes a very significant value and is based on solid growth, in particular in hair removal and body contouring applications, also due to a strong offer of innovative systems with Alexandrite technology (for hair removal ) and an articulated range of technologies for body treatments. The Surgery sector decreased (6,1%) due to the difficulty of accessing hospitals and the focus of hospital activities on Covid, a trend that had not yet affected the market at the beginning of 2020.

In the industrial applications sector, revenues showed an important overall recovery of approximately 153%, recording variations between 47% and approximately 206% in all the main segments. Growth in the cutting sector was 205,5%, with a turnover of 39.3 million of euro in the first quarter of 2021 compared to 12,8 million of euro in the same period of 2020, which suffered the halt of Chinese activities and partially of the Italian ones. Marking grew by 47,5% on the first quarter of 2020, recording sales for approximately 5,1 million of euro compared to 3,4 million of euro in 1Q 2020; sales of laser Sources recorded an approximately 47% increase compared to the same period of 2020 with a revenue at 1,1 million of euro.

In terms of geography, 63,8% growth was recorded in the Rest of the World with a revenue of

69.9 million of euro compared to 42,7 million of euro in 1Q 2020 and equal to 60.1% on total revenues, followed by Europe where sales were 23,6 million of euro compared to 18,7 million of euro in the same period of 2020, equal to 20,3% on total. In Italy the sales result was 22,8 million of euro compared to 11,5 million of euro in the first quarter of 2020, 19.6% of total revenues.

Gross Margin for the first quarter was 43,6 million of euro, an increase of approximately 38,5% compared to the 31,5 million of March 31, 2020 and a sequential improvement compared to the level recorded in the fourth quarter of 2020.

As an effect of the operating leverage and the substantial savings in sales and marketing expenses for trade fair and congress travel, prevented by the pandemic, EBITDA was widely positive for 15,6 million of euro, an increase of approximately 119,9% compared to 7,1 million of euros as of March 31, 2020. EBITDA Margin in the first quarter of 2021 was equal to 13.4% exceeding EBITDA Margin of 9,7% registered in 1Q 2020.

EBIT for the quarter was positive for 12.9 million of euro, up by 187,5% compared to the 4,5 million of euro of March 31, 2020. EBIT margin was 11,1% up on the 6,2% of the previous year and marking a very satisfactory level, in line with the Group's most ambitious objectives.

The pre-taxresult had a balance of approximately 14,1 million and recorded a significant 199,3% increase compared to the 4,7 million of March 31, 2020.

The net financial position of the Group was positive for approximately 75,8 million of euro, up compared to approximately 69,2 million of euro at 31 December 2020. The cash flows generated by operating activities covered the needs deriving from the physiological increase in working capital in this phase of growth and forecast of further rapid growth, and those resulting from capital expenditures. The share capital increase collected by the company in connection to the exercise of the stock options assigned to employees, summing up 3,2 million of euros in 3 months, also

3

contributed to the improved financial position. The solid financial position allows the Group to define its growth strategies with great freedom.

* * * * * * * * *

The manager in charge of preparing the corporate accounting records, Enrico Romagnoli, declares, pursuant to paragraph 2, article 154-bisof the Consolidated Finance Law, that the accounting disclosures provided in this document correspond to the accounting records, books and entries.

* * * * * * * * *

Other resolutions of the Bod

During the meeting, the Board of Directors appointed the members of the committees referred to in the Corporate Governance Code of listed companies and more specifically the "remuneration committee", the "control and risk committee, for transactions with related parties and for sustainability "and the" nomination committee ".

The Board of Directors also positively assessed, on the basis of the information available, the independence of the non-executive directors Fabia Romagnoli, Daniela Toccafondi and Michele Legnaioli.

Business outlook

The beginning of 2021 is confirming and surpassing the forecasts of rapid growth in turnover and profitability, in line with the growth path outlined before the pandemic. The Group is aware that the uncertainties still arising from the evolution of the pandemic and the effects of the relaunch measures could, even in the short term, negatively affect the markets on which it operates. At the moment we are experiencing a particularly positive phase of demand. The current trend in the acquisition of orders in the main application segments suggests the possibility of reaching 500 million in annual turnover while maintaining EBIT at around 10%.

**************

As required by Consob, the Quarterly report on March 31st, 2021 will be available for the public at our premises in Calenzano, at Borsa Italiana S.p.A., on our website www.elengroup.com("Investor Relations / Documenti Finanziari / Relazioni e Bilanci / 2021") from May 14th, 2021 and on authorized storage website www.emarketstorage.com.

4

CONFERENCE CALL

On Monday May 17th, 2021 at 15.00 CET (14:00 GMT) (9:00 EST), EL.EN. S.p.A. will hold a conference call discussing the Group's financial results. The following link can be used to participate:

EL.EN. S.p.A. Q1 Financial Results 2021 (Video Conference)

Join: https://polytemshirit.zoom.us/j/82312641303?pwd=NTU5cEtlRW5XaVE4UER3MHFXVGZnZz09

Meeting ID: 82312641303

Password: 720113

+39 0200667245 Italy (toll)

+39 02124128823 Italy (toll)

+1 2532158782 US (toll)

+1 3462487799 US (toll)

+1 6699006833 US (toll)

Prior to the conference call, download of the presentation will be available on the Investor relation page of the El.En. website: http://www.elengroup.com/en/investor-relations-en/company-presentations.

El.En., an Italian company, is the parent of a high-.tech industrial Group operating in the optoelectronics sector. Based on proprietary technology and multidisciplinary know-how, the El.En Group manufactures laser sources (gas, semiconductor, solid-state and liquid) and innovative laser systems for medical and industrial applications. The El.En. Group is the laser market leader in Italy and among the top operators in Europe. It designs, manufactures and sells worldwide:

  • Medical laser equipment used in dermatology, cosmetics, physiotherapy, dentistry and gynecology;
  • Industrial laser systems for applications ranging from cutting, marking and welding metals, wood, plastic and glass to decorating leather and textiles and restoring/conserving artwork;
  • Laser systems for scientific research

EL.EN has been listed on the Star (MTA) of Borsa Italian with a market capitalization amounts to Euro 684 million.

Cod. ISIN: IT0005188336

Code: ELN

Listed on MTA

Mkt cap.: 684 million of euro

Cod. Reuters: ELN.MI

Cod. Bloomberg: ELN IM

For further information:

El.En S.p.A.

Investor Relator

Enrico ROMAGNOLI - finance@elen.itTel. +39 055 8826807

Polytems HIR

Financial Communication, IR and Press Office

Bianca FERSINI MASTELLONI - b.fersini@polytemshir.itPaolo SANTAGOSTINO - p.santagostino@polytemshir.itSilvia MARONGIU - s.marongiu@polytemshir.it

Tel. +39 06-69923324 - 06 6797849

5

This is an excerpt of the original content. To continue reading it, access the original document here.

Disclaimer

El.En. S.p.A. published this content on 14 May 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 14 May 2021 13:56:03 UTC.


© Publicnow 2021
All news about EL.EN. S.P.A.
05/23EL.EN. S.P.A. : Ex-dividend day for final dividend
FA
05/16TRANSCRIPT : EL.En. S.p.A., Q1 2022 Earnings Call, May 16, 2022
CI
04/29EL EN S P A : Ordinary and Special Shareholder's meeting of El.En. S.p.A.
PU
04/20EL EN S P A : Communication of changes to the El.En.'s share capital
PU
04/15EL EN S P A : Publication of the form for delegation and of form for the proxy to the Appo..
PU
04/08EL EN S P A : Notice of the publication and availability of a new Report, prepared by the ..
PU
04/08EL EN S P A : Notice of the publication of the two lists for the appointment of the Board ..
PU
04/05EL EN S P A : Notice of filing of two lists for the election of the Board of Statutory Aud..
PU
04/04EL EN S P A : Annex 3f / 03-2022
PU
03/31EL EN S P A : Notice of the publication and availability of the 2021 Annual Financial Repo..
PU
More news
Financials
Sales 2022 659 M 696 M 696 M
Net income 2022 55,0 M 58,0 M 58,0 M
Net cash 2022 130 M 138 M 138 M
P/E ratio 2022 18,2x
Yield 2022 1,79%
Capitalization 1 001 M 1 056 M 1 056 M
EV / Sales 2022 1,32x
EV / Sales 2023 1,16x
Nbr of Employees -
Free-Float -
Chart EL.EN. S.P.A.
Duration : Period :
EL.En. S.p.A. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends EL.EN. S.P.A.
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 2
Last Close Price 12,54 €
Average target price 18,05 €
Spread / Average Target 43,9%
EPS Revisions
Managers and Directors
Andrea Cangioli Co-Chief Executive Officer & Executive Director
Gabriele Clementi Chairman & Co-Chief Executive Officer
Barbara Bazzocchi Co-Chief Executive Officer & Executive Director
Michele Legnaioli Independent Non-Executive Director
Fabia Romagnoli Independent Non-Executive Director
Sector and Competitors
1st jan.Capi. (M$)
EL.EN. S.P.A.-19.51%1 056
THERMO FISHER SCIENTIFIC-16.80%217 320
DANAHER CORPORATION-23.47%180 262
INTUITIVE SURGICAL, INC.-39.03%78 637
SIEMENS HEALTHINEERS AG-16.99%64 649
EDWARDS LIFESCIENCES CORPORATION-27.19%58 644